EP3071687

METHOD OF ENGINEERING CHEMOTHERAPY DRUG RESISTANT T-CELLS FOR IMMUNOTHERAPY

Status:
EP einkaleyfi: Þýðing ekki lögð inn
EP appl. date:
21.11.2014
EP published:
31.7.2019
EP application number:
14827176.0

EPO information:
European Patent Register

Max expiry date:
20.11.2034

Title:
METHOD OF ENGINEERING CHEMOTHERAPY DRUG RESISTANT T-CELLS FOR IMMUNOTHERAPY

Timeline

Today

21.11.2014EP application

31.7.2019EP Publication

Owner

Name:
Cellectis
Address:
8, rue de la Croix Jarry, 75013, Paris, FR

Inventor

Name:
VALTON, Julien
Address:
New York, NY, US

Name:
DUCHATEAU, Philippe
Address:
Draveil, FR

Name:
SOURDIVE, David
Address:
Levallois-Perret, FR

Priority

Number:
201361907874 P
Date:
22.11.2013
Country:
US

Number:
201470362
Date:
17.6.2014
Country:
DK

Classification

Categories:
C12N 5/0783

Upload documents

Email *

Reference number

Click here to upload document

EP3071687

METHOD OF ENGINEERING CHEMOTHERAPY DRUG RESISTANT T-CELLS FOR IMMUNOTHERAPY

Status:

EP appl. date:

EP published:

EP application number:

EPO information:

Max expiry date:

Title:

Timeline

Owner

Name:

Address:

Inventor

Name:

Address:

Name:

Address:

Name:

Address:

Priority

Number:

Date:

Country:

Number:

Date:

Country:

Classification

Categories:

Upload documents